fbpx

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
Manish Shah

Manish Shah, MD, discusses avelumab’s effectiveness based on results from the JAVELIN 100 study

Manish Shah of Weill Cornell Medicine explains the results of a recent study in which gastric cancer patients given either chemo or the checkpoint inhibitor Bavencio (avelumab) as maintenance treatment did equally well.

Read Source
DonateMore InfoDonateMore Info
We cannot gather at a gala event this year, but a pandemic cannot stop us from joining together to ensure that the search to find a cure for gastric (stomach) cancer continues.

Join with us to fuel the next wave of progress.

Every contribution moves us closer to a cure.
We cannot gather at a gala event this year, but a pandemic cannot stop us from joining together to ensure that the search to find a cure for gastric (stomach) cancer continues.

Join with us to fuel the next wave of progress.

Every contribution moves us closer to a cure.
X